• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异环磷酰胺外渗

Ifosfamide extravasation.

作者信息

Mateu J, Alzamora M, Franco M, Buisán M J

机构信息

Department of Pharmacy, Hospital Joan XXIII, Tarragona, Spain.

出版信息

Ann Pharmacother. 1994 Nov;28(11):1243-4. doi: 10.1177/106002809402801106.

DOI:10.1177/106002809402801106
PMID:7849337
Abstract

OBJECTIVE

To report a case in which a local reaction is attributed to an ifosfamide extravasation. Previously, extravasated ifosfamide has been considered a nonirritant.

CASE SUMMARY

A 54-year-old woman with a non-Hodgkin's lymphoma in stage IV B developed a local reaction in her right arm after an ifosfamide extravasation. No pressure was prescribed, no bandaging was applied on the affected area, and the limb was elevated to the heart level. In addition, chondroitinsulfatase 150 turbidity-reducing units was administered subcutaneously around the area. This procedure was repeated 12 hours later, resulting in a satisfactory decrease in the inflammatory signs and pain.

DISCUSSION

The local reaction in the patient's arm cannot be attributed to the hypertonicity of the infusing solution or to the vehicle of the infusate. The antidote used was chondroitinsulfatase, an enzyme similar to hyaluronidase. It enhances the systemic uptake of the drug from the tissue.

CONCLUSIONS

Extravasated ifosfamide is a potential irritant. General measures applied after its extravasation can be potentiated strongly by local subcutaneous administration of chondroitinsulfatase or hyaluronidase, repeated if necessary.

摘要

目的

报告一例局部反应被归因于异环磷酰胺外渗的病例。此前,外渗的异环磷酰胺一直被认为无刺激性。

病例摘要

一名54岁IV B期非霍奇金淋巴瘤女性在异环磷酰胺外渗后右臂出现局部反应。未采取加压措施,未对患处进行包扎,肢体抬高至心脏水平。此外,在该区域周围皮下注射了150浑浊度降低单位的硫酸软骨素酶。12小时后重复此操作,炎症体征和疼痛得到满意缓解。

讨论

患者手臂的局部反应不能归因于输注溶液的高渗性或输注液的载体。所使用的解毒剂是硫酸软骨素酶,一种与透明质酸酶类似的酶。它可增强药物从组织的全身摄取。

结论

外渗的异环磷酰胺具有潜在刺激性。异环磷酰胺外渗后采取的一般措施可通过局部皮下注射硫酸软骨素酶或透明质酸酶得到显著加强,必要时可重复注射。

相似文献

1
Ifosfamide extravasation.异环磷酰胺外渗
Ann Pharmacother. 1994 Nov;28(11):1243-4. doi: 10.1177/106002809402801106.
2
Treatment of extravasation from parenteral nutrition solution.
Ann Pharmacother. 1998 Jan;32(1):51-5. doi: 10.1345/aph.16487.
3
Treatment of extravasation of both doxorubicin and vincristine administration in a Y-site infusion.
Ann Pharmacother. 1996 Mar;30(3):244-6. doi: 10.1177/106002809603000306.
4
Extravasation of contrast media managed with recombinant human hyaluronidase.对比剂外渗的重组人透明质酸酶处理。
Am J Emerg Med. 2012 Nov;30(9):2102.e1-3. doi: 10.1016/j.ajem.2012.03.005. Epub 2012 May 23.
5
Successful dexrazoxane treatment of a potentially severe extravasation of concentrated doxorubicin.成功治疗潜在严重的多柔比星浓缩液外渗
Anticancer Drugs. 2010 Sep;21(8):790-4. doi: 10.1097/CAD.0b013e32833d9032.
6
Use of hyaluronidase for the treatment of extravasation of chemotherapeutic agents in six dogs.透明质酸酶用于治疗6只犬化疗药物外渗的研究
J Am Vet Med Assoc. 2002 Nov 15;221(10):1437-40, 1419-20. doi: 10.2460/javma.2002.221.1437.
7
Hyaluronidase as an antidote to extravasation of Vinca alkaloids: clinical results.透明质酸酶作为长春花生物碱外渗的解毒剂:临床结果
J Cancer Res Clin Oncol. 1994;120(8):505-6. doi: 10.1007/BF01191807.
8
[Extravasation of chemotherapeutic agents: prevention and therapy].[化疗药物外渗:预防与治疗]
Dtsch Med Wochenschr. 2005 Jan 7;130(1-2):33-7. doi: 10.1055/s-2005-837372.
9
Identification of highly concentrated dextrose solution (50% dextrose) extravasation and treatment--a clinical report.高浓度葡萄糖溶液(50%葡萄糖)外渗的识别与治疗——临床报告
Am J Emerg Med. 2013 May;31(5):886.e3-5. doi: 10.1016/j.ajem.2012.12.010. Epub 2013 Apr 18.
10
Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study.局部应用二甲亚砜预防刺激性细胞毒性药物外渗后软组织损伤:一项前瞻性临床研究。
J Clin Oncol. 1995 Nov;13(11):2851-5. doi: 10.1200/JCO.1995.13.11.2851.